COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,722 Articles (22,502 medRxiv, 8,220 bioRxiv)

Most recent first Previous |  Page 121: Articles 1201-1210  | Next

Comparison of Peripheral Nerve Injury Outcomes Between COVID-19 Survivors and Non-COVID Rehabilitation Inpatients: A Retrospective Study
Mondriguez-Gonzalez, A., Rothemich, B. M., Sheth, M. N., Swong, K. N., Franz, C. K.
10.1101/2024.08.22.24312439 — Posted: 2024-08-22
Long-term monitoring of SARS-CoV-2 load and variant composition at a large metropolitan wastewater treatment plant using a simple two-step direct capture RNA extraction, droplet digital PCR, and targeted mutation assays
Balogh, S. J., Sprouse, G. B., Beckman, K. B., Watson, R. H. B., Johnson, D. M., Pinkerton, L. D., Nollet, Y. H., Sealock, A. W., Atkins, W. S. C., Selenke, L. M., Kinney, J. A., Grady, P. J. R., Vanderbush, B., Daniel, J. J.
10.1101/2024.08.21.24311866 — Posted: 2024-08-21
Severe disease is not essential for a high neutralizing antibody response post-SARS-CoV-2 infection
Khairallah, A., Jule, Z., Piller, A., Bernstein, M., Reedoy, K., Ganga, Y., Gosnell, B., Karim, F., Moosa, Y., Ndung'u, T., Khan, K., Sigal, A.
10.1101/2024.08.21.24312063 — Posted: 2024-08-21
SARS-CoV-2 Omicron subvariant genomic variation associations with immune evasion in Northern California: A retrospective cohort study
Nugent, J. R., Wood, M. S., Liu, L., Bullick, T., Schapiro, J. M., Arunleung, P., Gautham, G., Getabecha, S., Morales, C., Amsden, L. B., Hsiao, C. A., Wadford, D. A., Wyman, S. K., Skarbinski, J.
10.1101/2024.08.21.24312253 — Posted: 2024-08-21
Fc-independent SARS-CoV-2 infection-enhancing antibodies decouple N-terminal and receptor-binding domains by cross-linking neighboring spikes
van Eerden, F. J., Li, S., Lusiany, T., Ismanto, H. S., Terada, T., Gerle, C., Akamatsu, K., Hirose, M., Sugihara, F., Chen, D. V., Kishikawa, J.-i., Kato, T., Liu, Y., Okada, M., Arase, H., Standley, D. M.
10.1101/2024.08.21.608921 — Posted: 2024-08-21
Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response
Lee, A. A., Amick, I., Aschenbrenner, J. C., Barr, H. A., Benjamin, J., Brandis, A., Cohen, G., Diaz-Tapia, R., Duberstein, S., Dixon, J., Cousins, D., Fairhead, M., Fearon, D., Frick, J., Gayvert, J., de Godoy, A. S., Griffen, E. J., Huber, K. V. M., Koekemoer, L., Lahav, N., Marples, P. G., McGovern, B. L., Mehlman, T., Robinson, M. C., Singh, U., Szommer, T., Tomlinson, C. W. E., Vargo, T., von Delft, F., Wang, S., White, K. M., Williams, E., Winokan, M.
10.1101/2024.08.19.608619 — Posted: 2024-08-21
Escape of SARS-CoV-2 variants KP1.1, LB.1 and KP3.3 from approved monoclonal antibodies
Planas, D., Staropoli, I., Planchais, C., Yab, E., Jeyarajah, B., Rahou, Y., Guivel-Benhassine, F., Prot, M., Lemoine, F., Enouf, V., Simon-Loriere, E., Mouquet, H., Rameix-Welti, M.-A., Schwartz, O.
10.1101/2024.08.20.608835 — Posted: 2024-08-21
Aging and viral evolution impair immunity against dominant pan-coronavirus-reactive T cell epitope
Loyal, L., Juerchott, K., Reimer, U., Meyer-Arndt, L., Henze, L., Mages, N., Kostrzanowski, J., Reus, B., Mangold, M., Kruse, B., Dingeldey, M., Sawitzki, B., Wenschuh, H., Michel, J., Grossegesse, M., Nitsche, A., Lachmann, N., Timmermann, B., Giesecke, C., Braun, J., Kern, F., Thiel, A.
10.1101/2024.08.21.608923 — Posted: 2024-08-21
SARS-CoV-2 Damages Cardiomyocytes Mitochondria and Implicates Long COVID-associated Cardiovascular Manifestations
Che, W., Guo, S., Wang, Y., Wan, X., Tan, B., Li, H., Ailipu, J., Zhu, M., Chen, Z., Li, P., Zhang, Z., Wang, Y., Huang, X., Wang, X., Zhu, J., Pan, X., Zhang, F., Wang, P., Zhao, J., Xu, Y., Liu, Z.
10.1101/2024.08.18.24311961 — Posted: 2024-08-20
Examining the Role of Social Environment on COVID-19 Infections and Vaccine Uptake Among Migrants in Japan: Findings from Nationwide Surveys in 2021 and 2023
Teng, Y., Sabel, C. E., Hanibuchi, T., Nakaya, T.
10.1101/2024.08.19.24312272 — Posted: 2024-08-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).